health day reporter
Monday, January 17, 2022 (HealthDay News) — More and more people turn to central business district or marijuana therapeutic product skin conditions like this acne or rosaceabut researchers warn that the science about its safety and power has not kept pace with demand.
When more than 500 adults were asked about their use of CBD (cannabidiol) or cannabis, 17.6% said they used over-the-counter cannabis products to treat skin conditions like acne, psoriasisrosacea or eczema More people are interested in trying these products without a dermatologist’s recommendation.
CBD is derived from the cannabis plant’s cousin, hemp, but unlike THC (delta-9-tetrahydrocannabinol), the active ingredient in marijuana, CBD won’t get you high.
“People use these products without the guidance of a doctor, and even those who don’t use them are interested in learning more,” said study author Adam Friedman, MD, chair of dermatology at the George Washington School of Medicine and Health Sciences in Washington DC
It’s time for science to catch up, he said.
There is some promising early animal data suggesting that these products may help treat inflammatory skin conditions. “We know that cannabinoids activate the body’s resolvin pathway, which resolves inflammation“Cannabinoids set the stage for inflammation to address and recruit players that are critical to clearing inflammatory damage.”
About 89% said cannabis or other cannabis products are useful in treating skin conditions, and most said they would be willing to try one of these products if given the green light by their dermatologist.
Not regulated by the FDA
Two-thirds of those who saw a dermatologist were told to try CBD products, mainly for acne and psoriasis. Fewer than 8 percent of these people use medical marijuana, which requires a dermatologist’s approval card.
Buyers beware, however, when it comes to CBD, as these products are not regulated by the U.S. Food and Drug Administration, just like pharmaceuticals, Friedman said. He added that medical marijuana requires a prescription card issued by a doctor and can only be purchased from state-run dispensaries, so there is more quality control.
So, how do you judge whether the product you choose is good or not?
Always check the Certificate of Analysis (COA) for CBD products. Friedman said the document provides any test results for supplements, which the company can release voluntarily. “If it’s not online, contact the company, and if they don’t share it, that’s a red flag,” he noted.
Also look at other ingredients, he says, because “if you’re sensitive to other actives, you’re going to react.”
Friedman stressed that these products should never be used in place of prescription treatments for skin conditions.
The findings were published in the January issue of Journal of Dermatological Drugs.
more research needed
Other experts not involved in the study noted that there is still a lot to learn about the role of CBD and medical marijuana in skin and other conditions.
“From the right CBD or THC ingredients, the right dosage, and the right formulation, everything still needs to be hammered out,” said Dr. Peter Lio, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago.
“There is some evidence that topical CBD products can have antipruritic, anti-inflammatory and even wound healing properties in skin conditions,” he said. “These also appear to be very safe and don’t have the same issues as products containing THC, the psychoactive component of the cannabis plant.”
Always do a patch test, Lio stresses: “Any new product can cause problems, especially for those with more sensitive skin.”
It makes sense that people are turning to these products, says Dr. Mark Moyad. He is the Jenkins/Pokempner Director of Preventive and Alternative Medicine at the University of Michigan Medical Center in Ann Arbor.
“The unmet, unmet or unmet needs and expectations of some traditional options may motivate people to try CBD or medical marijuana For skin conditions,” explains Moyad.
Unfortunately, drug interactions and risks are being quickly understood, he noted.
“These products are here to stay, and people need answers, which means more money should be spent on objective research, because we need to find out where these products might actually be useful,” Moyad said.
Harvard Medical School has more information on cannabidiol.
Sources: Adam Friedman, MD, Professor and Chair of Dermatology at the George Washington School of Medicine and Health Sciences, Washington, D.C.; Peter Lio, MD, Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine in Chicago; Mark Moyad , MD, MPH, Jenkins/Pokempner Director of Preventive and Alternative Medicine, University of Michigan Medical Center, Ann Arbor; Journal of Dermatological DrugsJanuary 2022